Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study

被引:1126
|
作者
Hofman, A
Ott, A
Breteler, MMB
Bots, ML
Slooter, AJC
vanHarskamp, F
vanDuijn, CN
Van Broeckhoven, C
Grobbee, DE
机构
[1] ERASMUS UNIV ROTTERDAM, SCH MED, DEPT NEUROL, NL-3000 DR ROTTERDAM, NETHERLANDS
[2] UNIV INSTELLING ANTWERP, BORN BUNGE FDN, NEUROGENET LAB, B-2610 WILRIJK, BELGIUM
来源
LANCET | 1997年 / 349卷 / 9046期
关键词
D O I
10.1016/S0140-6736(96)09328-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Vascular disorders have been implicated in dementia, but whether atherosclerosis is related to the most frequent type of dementia, Alzheimer's disease, is not known. The apolipoprotein-E genotype has been associated with Alzheimer's disease, and we postulate that it plays a part, together with atherosclerosis, in the aetiology of Alzheimer's disease. We investigated the frequency of dementia and its subtypes in relation to atherosclerosis and apolipoprotein E. Methods We did a population-based study of 284 patients with dementia, 207 of whom had Alzheimer's disease, and 1698 individuals who were not demented. Indicators of atherosclerosis included vessel wall thickness and plaques of the carotid arteries, assessed by ultrasonography, and the ratio of ankle-to-brachial systolic blood pressure as a measure of generalised atherosclerosis. Based on these indicators participants were scored from 0 (no atherosclerosis) to 3 (severe atherosclerosis) for degree of atherosclerosis. Apolipoprotein-E polymorphisms were assessed in 246 patients and in 928 controls. Findings All indicators of atherosclerosis were associated with dementia (odds ratios ranging from 1.3 to 1.9) and its major subtypes Alzheimer's disease (odds ratios 1.3-1.8) and vascular dementia (odds ratios 1.9-3.2). The frequencies of all dementia, Alzheimer's disease, and vascular dementia increased with the degree of atherosclerosis. The odds ratio for Alzheimer's disease in those with severe atherosclerosis compared with those without atherosclerosis was 3.0 (95% CI 1.5-6.0; p=0.001). In participants with the apolipoprotein-E epsilon 4 genotype and an atherosclerosis score of 2 or 3 the odds ratio for all dementia was 4.5 (2.0-10.1; p<0.001), for Alzheimer's disease was 3.9 (1.6-9.6; p=0.002), and for vascular dementia was 19.8 (4.1-95.0; p<0.001). Interpretation These findings suggest that dementia and its two major subtypes Alzheimer's disease and vascular dementia are associated with atherosclerosis and that there is an interaction between apolipoprotein E and atherosclerosis in the aetiology of Alzheimer's disease.
引用
收藏
页码:151 / 154
页数:4
相关论文
共 50 条
  • [1] Apolipoprotein E genotype and progression of Alzheimer's disease: the Rotterdam study
    Slooter, AJC
    Houwing-Duistermaat, JJ
    van Harskamp, F
    Cruts, M
    Van Broeckhoven, C
    Breteler, MMB
    Hofman, A
    Stijnen, T
    van Duijn, CM
    JOURNAL OF NEUROLOGY, 1999, 246 (04) : 304 - 308
  • [2] Apolipoprotein E genotype and progression of Alzheimer’s disease: the Rotterdam Study
    A. J. C. Slooter
    Jeanine J. Houwing-Duistermaat
    Frans van Harskamp
    Marc Cruts
    Christine Van Broeckhoven
    Monique M. B. Breteler
    Albert Hofman
    T. Stijnen
    Cornelia M. van Duijn
    Journal of Neurology, 1999, 246 : 304 - 308
  • [3] The apolipoprotein E genotype in Parkinson's disease with and without dementia: The Rotterdam Study
    Harhangi, SB
    de Rijk, MC
    van Duijn, CM
    Hofman, A
    Breteler, MMB
    NEUROLOGY, 1999, 52 (06) : A12 - A13
  • [4] Serum apolipoprotein E level is not increased in Alzheimer's disease: the Rotterdam study
    Slooter, AJC
    de Knijff, P
    Hofman, A
    Cruts, M
    Breteler, MMB
    Van Broeckhoven, C
    Havekes, LM
    van Duijn, CM
    NEUROSCIENCE LETTERS, 1998, 248 (01) : 21 - 24
  • [5] Apolipoprotein E and carotid artery atherosclerosis - The Rotterdam study
    Slooter, AJC
    Bots, ML
    Havekes, LM
    del Sol, AI
    Cruts, M
    Grobbee, DE
    Hofman, A
    Van Broeckhoven, C
    Witteman, JCM
    van Duijn, CM
    STROKE, 2001, 32 (09) : 1947 - 1952
  • [6] Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond
    Mahley, RW
    Huang, YD
    CURRENT OPINION IN LIPIDOLOGY, 1999, 10 (03) : 207 - 217
  • [7] Serum apolipoprotein E level and dementia: The Rotterdam Study
    Slooter, AJC
    de Knijff, P
    Hofman, A
    Van Broeckhoven, C
    Havekes, LM
    van Duijn, CM
    NEUROLOGY, 1998, 50 (04) : A231 - A231
  • [8] Serum apolipoprotein E is associated with long-term risk of Alzheimer's disease: The Rotterdam Study
    Wolters, Frank J.
    Koudstaal, Peter J.
    Hofman, Albert
    van Duijn, Cornelia M.
    Ikram, M. Arfan
    NEUROSCIENCE LETTERS, 2016, 617 : 139 - 142
  • [9] Implication of apolipoprotein e polymorphisms in the atherosclerosis and Alzheimer's disease physiopathology
    Narvaez Lopez, Edgar Jonathan
    Bravo Pelaez, Jose Andres
    Almeida Lozano, Karen Alexandra
    Alvarez Rivera, Cristian Geovanny
    Mendoza Argandona, Cesar Augusto
    Morales Sanchez, Alex Marcelo
    Godos Rivera, Digna Tatiana
    Del Salto Ocana, Tatiana Elizabeth
    Catota Camacho, Maria Magdalena
    REVISTA LATINOAMERICANA DE HIPERTENSION, 2018, 13 (02): : 97 - 102
  • [10] Apolipoprotein E genotype, atherosclerosis, and cognitive decline: the Rotterdam study
    Slooter, AJC
    van Duijn, CM
    Bots, ML
    Ott, A
    Breteler, MB
    De Voecht, J
    Wehnert, A
    de Knijff, P
    Havekes, LM
    Grobbee, DE
    Van Broeckhoven, C
    Hofman, A
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1998, (53): : 17 - 29